Si è verificato un errore durante il caricamento della pagina.
Il nostro team è stato avvisato ma contattaci tramite il Widget assistenza email se il problema persiste.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 20,5x - 22,7x | 21,6x |
| Selected Fwd EBIT Multiple | 10,2x - 11,3x | 10,8x |
| Fair Value | ₩17.666 - ₩19.588 | ₩18.627 |
| Upside | -18,6% - -9,7% | -14,2% |
| Benchmarks | Ticker | Full Ticker |
| INSAN Inc. | A277410 | KOSDAQ:A277410 |
| Icure Pharmaceutical Incorporation | A175250 | KOSDAQ:A175250 |
| Tonymoly Co., Ltd | A214420 | KOSE:A214420 |
| Outin Futures Co., Ltd | A227610 | KOSDAQ:A227610 |
| Manyo Factory Co., Ltd | A439090 | KOSDAQ:A439090 |
| Genic Co., Ltd. | A123330 | KOSDAQ:A123330 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| A277410 | A175250 | A214420 | A227610 | A439090 | A123330 | ||
| KOSDAQ:A277410 | KOSDAQ:A175250 | KOSE:A214420 | KOSDAQ:A227610 | KOSDAQ:A439090 | KOSDAQ:A123330 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -27.2% | NM- | NM- | NM- | NM- | NM- | |
| 3Y CAGR | -53.8% | NM- | NM- | NM- | NM- | NM- | |
| Latest Twelve Months | -85.8% | -1.4% | 26.4% | -963.1% | 20.8% | 249.9% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 15.5% | -35.0% | -6.0% | -21.0% | 19.1% | -5.9% | |
| Prior Fiscal Year | 15.4% | -45.6% | 6.4% | -1.0% | 24.1% | -14.3% | |
| Latest Fiscal Year | 2.5% | -48.8% | 6.9% | -9.9% | 15.1% | 12.1% | |
| Latest Twelve Months | 2.5% | -44.0% | 6.9% | -9.9% | 14.7% | 12.1% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.94x | 1.17x | 1.23x | 1.22x | 1.82x | 3.61x | |
| EV / LTM EBITDA | 22.2x | -4.0x | 11.8x | -26.5x | 11.6x | 23.5x | |
| EV / LTM EBIT | 77.6x | -2.7x | 17.9x | -12.4x | 12.4x | 29.9x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -12.4x | 12.4x | 77.6x | ||||
| Historical EV / LTM EBIT | -60.1x | -9.8x | 29.9x | ||||
| Selected EV / LTM EBIT | 20.5x | 21.6x | 22.7x | ||||
| (x) LTM EBIT | 6,025 | 6,025 | 6,025 | ||||
| (=) Implied Enterprise Value | 123,509 | 130,009 | 136,510 | ||||
| (-) Non-shareholder Claims * | (4,650) | (4,650) | (4,650) | ||||
| (=) Equity Value | 118,859 | 125,359 | 131,860 | ||||
| (/) Shares Outstanding | 7.8 | 7.8 | 7.8 | ||||
| Implied Value Range | 15,190.25 | 16,021.01 | 16,851.77 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 15,190.25 | 16,021.01 | 16,851.77 | 21,700.00 | |||
| Upside / (Downside) | -30.0% | -26.2% | -22.3% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A277410 | A175250 | A214420 | A227610 | A439090 | A123330 | |
| Enterprise Value | 62,253 | 68,688 | 211,886 | 40,790 | 228,403 | 174,445 | |
| (+) Cash & Short Term Investments | 12,537 | 22,492 | 24,271 | 8,129 | 87,270 | 1,290 | |
| (+) Investments & Other | 2,180 | 8,091 | 48,165 | 1,611 | 293 | 0 | |
| (-) Debt | (30,882) | (37,728) | (64,780) | (23,526) | (4,452) | (5,940) | |
| (-) Other Liabilities | (329) | (696) | (6,810) | 2,312 | 0 | 0 | |
| (-) Preferred Stock | 0 | (2,624) | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 45,760 | 58,222 | 212,734 | 29,316 | 311,515 | 169,796 | |
| (/) Shares Outstanding | 37.7 | 37.4 | 23.9 | 35.4 | 16.4 | 7.8 | |
| Implied Stock Price | 1,214.00 | 1,558.00 | 8,900.00 | 827.00 | 19,020.00 | 21,700.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,214.00 | 1,558.00 | 8,900.00 | 827.00 | 19,020.00 | 21,700.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |